CN Patent
CN109535217B — 一种奥贝胆酸的精制方法
Assigned to Livzon New North River Pharmaceutical Co ltd · Expires 2020-04-14 · 6y expired
What this patent protects
本发明公开了一种奥贝胆酸的精制方法,包括将奥贝胆酸粗品溶解,加入环糊精混合一定时间后分离环糊精,精制得到奥贝胆酸。本发明方法利用成本低廉的环糊精对奥贝胆酸进行精制,能够有效地除去奥贝胆酸成品异构体杂质等杂质。相比于传统的奥贝胆酸精制方法,本发明的方法反应条件温和,步骤简单,得到的合格成品纯度高,简化的步骤的同时提高了产品收率。
USPTO Abstract
本发明公开了一种奥贝胆酸的精制方法,包括将奥贝胆酸粗品溶解,加入环糊精混合一定时间后分离环糊精,精制得到奥贝胆酸。本发明方法利用成本低廉的环糊精对奥贝胆酸进行精制,能够有效地除去奥贝胆酸成品异构体杂质等杂质。相比于传统的奥贝胆酸精制方法,本发明的方法反应条件温和,步骤简单,得到的合格成品纯度高,简化的步骤的同时提高了产品收率。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.